Draig Therapeutics
Developing transformative, best-in-class neuropsychiatric therapies
$65MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Developing transformative, best-in-class neuropsychiatric therapies
Trains workforces in AI and tech skills through apprenticeships for enterprise employers
Provides end-to-end AI platform for autonomous driving licensed to automakers and mobility platforms
Develops inhaled therapies for severe respiratory diseases